Marker Therapeutics's total assets for Q1 2025 were $16.99M, a decrease of -22.84% from the previous quarter. MRKR total liabilities were $2.50M for the fiscal quarter, a -27.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.